Home > > > > > Report Detail

Investigation Report on China Lentinan Market, 2010-2019

Publisher Name :
Date: 02-Jul-2015
No. of pages: 40

Currently, the incidence of malignant cancer is growing at 3%5% with more and more younger people. The number of new cases of cancer exceeds 3 million each year with six confirmed cases every one minute. And bad living habits and changed environment have become the main risk factors of cancer.

Carbohydrate drug is the bioactive carbohydrate and its derivatives isolated from animals, plants, microbes and sea creatures. The diversity of carbohydrate structure determines the diversity of carbohydrate drug's bioactivity. One category of carbohydrate drugs is the immunoregulatory antitumor polysaccharide isolated from plants and microbes. Although chemotherapy drugs are the most common drugs for malignant cancer in the clinic, polysaccharide is with no side effects. Therefore, more and more polysaccharide drugs are used for the treatment or assistive treatment of tumor. Currently, fungi polysaccharide like lentinan, schizophyllan, ganoderan and pachymaran as well as higher plants polysaccharide such as astragalus polysaccharide and panaxan have been widely used in the clinic as immunomodulators and antitumor drugs.

As an intravenous biological response modifier, lentinan features potent antitumor effects, remarkably prolonged life, improved life quality and mild side effects. First developed by Japan, lentinan was approved to enter China in 1988. Although the practical use has confirmed lentinan's efficacy, its market size has been limited due to its high price.

After entering the 21st century, lentinan has become able to be produced domestically at a relatively low price. Therefore, its market size grows at an increasing rate, annual sales value rising from less than CNY 200 million in 2005 to CNY 473 million in 2014 and CAGR during this period reaching 11.3%. JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory, Chuang Li Yao Ye, Kanion Pharmaceutical, Nanjing Luye Sike Pharma Co., Ltd and Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory had the largest market share of about 39% for sales value in 2014.

With worsened environmental pollution and lifestyle change brought about by economic development, the incidence of cancer keeps growing. Therefore, the market size of lentinan in China is expected to grow too.

Readers can get at least the following information from this report:


  • market size of lentinan in China

  • competitive landscape of lentinan in Chinese market

  • price of lentinan made by different enterprises in China

  • market outlook of lentinan in China


The author suggests the following groups of people purchase this report:


  • manufacturers of immunomodulator

  • manufacturers of antitumor drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Lentinan Market, 2010-2019

Table of Contents

1 Related Concepts of Lentinan
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Lentinan in China
2.1 Patent and Approval Status of Lentinan in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Lentinan in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Lentinan in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Lentinan in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Lentinan in Chinese Hospitals in 2014
6.1 Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd
6.2 Nanjing Luye Sike Pharma Co., Ltd (Trade Name: TIANDIXIN)
6.3 Kanion Pharmaceutical
6.4 Apeloa Kangyu
6.5 Chuang Li Yao Ye
6.6 JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory

7 Major Manufacturers of Lentinan in Chinese Market, 2010-2014
7.1 Kaifeng Pharmaceutical (Group) Co., Ltd
7.2 Chuang Li Yao Ye
7.3 JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory
7.4 Kanion Pharmaceutical
7.5 Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd

8 Market Outlook of Lentinan in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Lentinan in China
Chart Approval Information of Lentinan in China
Chart Sales Status of Lentinan in China
Chart Sales Value of Lentinan in China, 2010-2014
Chart Sales Value of Lentinan in Some Regions in China, 2010-2014
Chart Sales Volume of Lentinan in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Lentinan for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Made by JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Made by Nanjing Luye Sike in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Made by Shanxi Zhendong Taisheng in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Made by Kanion in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Made by Chuang Li in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Made by Other Enterprises in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Injections in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Tablets in China, 2010-2014
Chart Sales Value and Market Share of Lentinan Capsules in China, 2010-2014
Chart Price of Lentinan Made by Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lentinan Made by Nanjing Luye Sike Pharma Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lentinan Made by Kanion Pharmaceutical in Some Chinese Cities in 2014
Chart Price of Lentinan Made by Apeloa Kangyu in Some Chinese Cities in 2014
Chart Price of Lentinan Made by Chuang Li Yao Ye in Some Chinese Cities in 2014
Chart Price of Lentinan Made by JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory in Some Chinese Cities in 2014

  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs